On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity-An observational study.

Autor: Halbmayer LM; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Kofler M; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Hitzenberger G; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Matzak H; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Fava E; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Genelin E; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Werkmann M; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Saltuari L; Department of Neurorehabilitation, Hospital of Vipiteno (SABES-ASDAA), Vipiteno, Italy.; Research Unit for Neurorehabilitation, Bolzano, Italy., Versace V; Department of Neurorehabilitation, Hospital of Vipiteno (SABES-ASDAA), Vipiteno, Italy., Dobesberger J; Rehabilitation Center Großgmain, Pensionsversicherungsanstalt, Teaching Hospital of Paracelsus Medical University, Salzburg, Austria., Pucks-Faes E; Department of Neurology, Hochzirl Hospital, Zirl, Austria.

Publikováno v: Brain and behavior [Brain Behav] 2022 May; Vol. 12 (5), pp. e2566. Date of Electronic Publication: 2022 Apr 10.

Ist die endogene Kreatinin-Clearance eine geeignete Basis für die Berechnung von Eliminationshalbwertszeiten des Gentamicins?

Autor: Hitzenberger G, Rameis H, Jaschek I, Graninger W

Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 105:1650-1654

The elimination half life of gentamicin after intravenous administration of 80 mg of Refobacin was determined experimentally in 24 patients with normal and variably reduced renal function in the agar diffusion test. Experimentally found elimination h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::64f2efbc81ec781f9163cefc328df759
https://doi.org/10.1055/s-2008-1070931

Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan

Autor: A. M. G. Bunt, Vogel Dr, Thomas Dumortier, Cuevas Jh, Ronald D. Smith, Hitzenberger G, Aroca Martinez Gj, Rodriguez Chavez, Garcia Lh, Lara Teran J, Middlemost Sj, Carbajal Et, Leao Neves P, Monterroso Vh

Publikováno v: Advances in Therapy. 17:117-131

The efficacy and safety of Iosartan and valsartan were evaluated in a multicenter, double-blind, randomized trial in patients with mild to moderate essential hypertension. Blood pressure responses to once-daily treatment with either losartan 50 mg (n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7c8e7972e2d64b7dccb54dbd93cf9fbb
https://doi.org/10.1007/bf02854844

脑损伤后慢性意识障碍康复影响因素及 治疗策略的回顾性分析.

Autor: 何志杰¹, 吴军发¹, 汤昕未¹, 吴毅¹, 陆蓉蓉¹

Publikováno v: Chinese Journal of Rehabilitation Medicine. 2024, Vol. 39 Issue 8, p1122-1142. 9p.

Intrathecal Baclofen Trial Before Device Implantation: 12-Year Experience With Continuous Administration.

Autor: Pucks-Faes E; Department of Neurology, Hochzirl Hospital, Zirl, Austria. Electronic address: elke.pucks-faes@tirol-kliniken.at., Matzak H; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Hitzenberger G; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Genelin E; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Halbmayer LM; Department of Neurology, Hochzirl Hospital, Zirl, Austria., Fava E; Department for Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Innsbruck, Austria., Fritz J; Department for Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Innsbruck, Austria., Saltuari L; Department of Neurology, Hochzirl Hospital, Zirl, Austria; Research Unit for Neurorehabilitation, South Tyrol, Bolzano, Italy.

Publikováno v: Archives of physical medicine and rehabilitation [Arch Phys Med Rehabil] 2019 May; Vol. 100 (5), pp. 837-843. Date of Electronic Publication: 2018 Oct 26.